Japanese Market Modestly Higher

RTTNews | 340 hari yang lalu
Japanese Market Modestly Higher

(RTTNews) - The Japanese stock market is modestly higher on Thursday, recouping the losses in the previous session, with the Nikkei 225 just below the 31,000 mark, despite the broadly negative cues from global markets overnight, boosted by gains in exporters and technology stocks. Traders also digested data that showed Japanese manufacturing activity climbed back into expansion territory in May. The benchmark Nikkei 225 Index is up 77.48 points or 0.25 percent to 30,965.36, after touching a high of 31,185.05 earlier. Japanese stocks closed sharply lower on Wednesday.

Market heavyweight SoftBank Group is surging almost 6 percent and Uniqlo operator Fast Retailing is edging up 0.3 percent. Among automakers, Toyota is gaining almost 2 percent, while Honda is edging down 0.5 percent.

In the tech space, Screen Holdings is edging up 0.1 percent and Tokyo Electron is adding almost 1 percent, while Advantest is losing more than 1 percent.

In the banking sector, Mitsubishi UFJ Financial is gaining almost 2 percent and Mizuho Financial is edging up 0.2 percent, while Sumitomo Mitsui Financial is edging down 0.1 percent.

Among the major exporters, Mitsubishi Electric is gaining 1.5 percent, Canon is adding almost 1 percent, Sony is advancing almost 2 percent and Panasonic is edging up 0.5 percent.

Among the other major gainers, Citizen Watch is surging almost 6 percent and Japan Steel Works is gaining almost 5 percent, while Fujitsu and Kajima are adding almost 4 percent each. Mitsubishi Corp. and Marui Group are up almost 3 percent each.

Conversely, Pacific Metals is losing more than 4 percent and Mitsubishi Motors is declining almost 3 percent.

In economic news, the manufacturing sector in Japan climbed back into expansion territory in May, the latest survey from Jibun Bank revealed on Thursday with a manufacturing PMI score of 50.6. That's up from 49.5, and it moves above the boom-or-bust line of 50 that separates expansion from contraction.

In the currency market, the U.S. dollar is trading in the lower 139 yen-range on Thursday.

On Wall Street, stock ended weak on Wednesday after languishing in negative territory right through the day's session. The weakness in the market came as traders kept a close eye on developments regarding the bill to raise the U.S. debt ceiling and avoid potentially disastrous default.

The major averages all ended with moderate losses despite coming off the day's lows. The Dow ended the session at 32,908.27 with a loss of 134.51 points or 0.41 percent. The S&P 500 settled with a loss of 25.69 points or 0.61 percent at 4,179.83, while the Nasdaq ended down 82.14 points or 0.63 percent at 12,935.29.

The major European markets also showed significant moves to the downside on the day. The U.K.'s FTSE 100 ended 1.01 percent down, while Germany's DAX and France's CAC 40 both lost about 1.55 percent.

Crude oil prices fell sharply on Wednesday as worries about fuel demand resurfaced, while a stronger dollar also weighed on oil prices. West Texas Intermediate Crude oil futures for July slumped $1.37 or 2 percent at $68.09 a barrel.

read more
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | 4h 6menit yang lalu
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 4h 27menit yang lalu
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 5h 6menit yang lalu
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 5h 10menit yang lalu
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 6h 12menit yang lalu
Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone investor confidence improved for the seventh straight month in May to hit the highest level since February 2022 as both current situation and expectations rose in small but steady steps, a closely watched survey showed on Monday. The investor confidence index posted -3.6 in May, the behavioral research institute Sentix reported. The score was forecast to improve moderately to -4.8.
RTTNews | 6h 21menit yang lalu